Insider · CIK 0001828217
Floyd Robert Michael
Reports to the SEC for 1 company · HANOVER, MD
Transactions
24
Companies
1
Filings
14
CIK
0001828217
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-02-09 | PCSAProcessa Pharmaceuticals, Inc.A Award | +$8,000 |
| 2023-01-01 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2023-01-01 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2022-12-31 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2022-10-06 | PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2022-10-06 | PCSAProcessa Pharmaceuticals, Inc.F Tax Payment | — |
| 2022-09-30 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2022-08-16 | PCSAProcessa Pharmaceuticals, Inc.G Gift | — |
| 2022-06-30 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2022-04-01 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2022-03-31 | PCSAProcessa Pharmaceuticals, Inc.G Gift | — |
| 2022-03-31 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-12-31 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-12-31 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-11-01 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-10-06 | PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2021-10-06 | PCSAProcessa Pharmaceuticals, Inc.F Tax Payment | — |
| 2021-09-30 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-09-30 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-07-08 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-07-08 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-07-08 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2021-06-22 | PCSAProcessa Pharmaceuticals, Inc.P Purchase | +$14.1K |
| 2021-06-08 | PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
Recent filings
- 4Floyd Robert Michael0001567619-23-002404SEC(opens sec.gov)
- 4Floyd Robert Michael0001567619-23-000326SEC(opens sec.gov)
- 4Floyd Robert Michael0001567619-22-018383SEC(opens sec.gov)
- 4Floyd Robert Michael0001567619-22-018059SEC(opens sec.gov)
- 4Floyd Robert Michael0001567619-22-016598SEC(opens sec.gov)
- 4Floyd Robert Michael0001567619-22-013684SEC(opens sec.gov)
- 4Floyd Robert Michael0001567619-22-008367SEC(opens sec.gov)
- 4Floyd Robert Michael0001567619-22-007993SEC(opens sec.gov)
- 4/AFloyd Robert Michael0001567619-22-000718SEC(opens sec.gov)
- 4/AFloyd Robert Michael0001567619-22-000773SEC(opens sec.gov)
- 4Floyd Robert Michael0001567619-22-000296SEC(opens sec.gov)
- 4Floyd Robert Michael0001567619-21-018171SEC(opens sec.gov)
- 4Floyd Robert Michael0001567619-21-017831SEC(opens sec.gov)
- 4Floyd Robert Michael0001567619-21-013195SEC(opens sec.gov)
Companies
Address
C/O PROCESSA PHARMACEUTICALS, INC. 7380 COCA COLA DRIVE, SUITE 106
HANOVER, MD, 21076